Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingyi Liu

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
Archives of Toxicology|September 11, 2024
Interleukin-9 promotes EMT-mediated PM<sub>2.5</sub>-induced pulmonary fibrosis by activating the STAT3 pathwayYuxuan Li, Yi Zhong, Chenwen Li, et al.
Cephalalgia : an International Journal of Headache|December 9, 2024
Effect of preventive treatment with atogepant on quality of life, daily functioning, and headache impact across the spectrum of migraine: Findings from three double-blind, randomized, phase 3 trialsChristopher Gottschalk, Pranav Gandhi, Patricia Pozo-Rosich, et al.
Annals of Surgical Oncology|January 16, 2023
Short- and Long-Term Outcomes of Indocyanine Green Fluorescence Navigation- Versus Conventional-Laparoscopic Hepatectomy for Hepatocellular Carcinoma: A Propensity Score-Matched, Retrospective, Cohort StudyFusheng Liu, Haitao Wang, Weijie Ma, et al.
Journal of Environmental Management|March 22, 2025
Soil carbon stability regulate carbon dynamics following large-scale afforestationQi Zhang, Hanyu Liu, Jiale He, et al.
International Journal of Nanomedicine|August 14, 2024
Liver Extracellular Vesicles and Particles Enriched β-Sitosterol Effectively Promote Liver Regeneration in MiceXiangdong Gongye, Peng Xia, Tianyin Ma, et al.
Cancer Research|August 21, 2025
The Acetyltransferase ARD1 Induces Glutathione Synthesis to Facilitate Ferroptosis Evasion in Hepatocellular CarcinomaYingyi Liu, Fu-Sheng Liu, Jie Liu, et al.
Headache|July 3, 2026
Weight loss with atogepant in the long-term treatment of migraine: An interim analysis of a safety endpoint from a phase 3, multicenter, open-label, 156-week extension studyDale S Bond, Jonathan H Smith, Alexandra Sinclair, et al.
Nature Medicine|May 12, 2025
Ubrogepant for the treatment of migraine prodromal symptoms: an exploratory analysis from the randomized phase 3 PRODROME trialPeter J Goadsby, Jessica Ailani, David W Dodick, et al.
Dermatology (Basel, Switzerland)|October 30, 2024
Efficacy and Safety of Upadacitinib versus Dupilumab Treatment for Moderate-to-Severe Atopic Dermatitis in Four Body Regions: Analysis from the Heads Up StudyJacob P Thyssen, David Rosmarin, Antonio Costanzo, et al.
Acta Dermato-Venereologica|May 6, 2024
Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated with UpadacitinibShawn G Kwatra, Marjolein De Bruin-Weller, Jonathan I Silverberg, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Archives of Toxicology|September 11, 2024
Interleukin-9 promotes EMT-mediated PM<sub>2.5</sub>-induced pulmonary fibrosis by activating the STAT3 pathwayYuxuan Li, Yi Zhong, Chenwen Li, et al.
Cephalalgia : an International Journal of Headache|December 9, 2024
Effect of preventive treatment with atogepant on quality of life, daily functioning, and headache impact across the spectrum of migraine: Findings from three double-blind, randomized, phase 3 trialsChristopher Gottschalk, Pranav Gandhi, Patricia Pozo-Rosich, et al.
Annals of Surgical Oncology|January 16, 2023
Short- and Long-Term Outcomes of Indocyanine Green Fluorescence Navigation- Versus Conventional-Laparoscopic Hepatectomy for Hepatocellular Carcinoma: A Propensity Score-Matched, Retrospective, Cohort StudyFusheng Liu, Haitao Wang, Weijie Ma, et al.
Journal of Environmental Management|March 22, 2025
Soil carbon stability regulate carbon dynamics following large-scale afforestationQi Zhang, Hanyu Liu, Jiale He, et al.
International Journal of Nanomedicine|August 14, 2024
Liver Extracellular Vesicles and Particles Enriched β-Sitosterol Effectively Promote Liver Regeneration in MiceXiangdong Gongye, Peng Xia, Tianyin Ma, et al.
Cancer Research|August 21, 2025
The Acetyltransferase ARD1 Induces Glutathione Synthesis to Facilitate Ferroptosis Evasion in Hepatocellular CarcinomaYingyi Liu, Fu-Sheng Liu, Jie Liu, et al.
Headache|July 3, 2026
Weight loss with atogepant in the long-term treatment of migraine: An interim analysis of a safety endpoint from a phase 3, multicenter, open-label, 156-week extension studyDale S Bond, Jonathan H Smith, Alexandra Sinclair, et al.
Nature Medicine|May 12, 2025
Ubrogepant for the treatment of migraine prodromal symptoms: an exploratory analysis from the randomized phase 3 PRODROME trialPeter J Goadsby, Jessica Ailani, David W Dodick, et al.
Dermatology (Basel, Switzerland)|October 30, 2024
Efficacy and Safety of Upadacitinib versus Dupilumab Treatment for Moderate-to-Severe Atopic Dermatitis in Four Body Regions: Analysis from the Heads Up StudyJacob P Thyssen, David Rosmarin, Antonio Costanzo, et al.
Acta Dermato-Venereologica|May 6, 2024
Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated with UpadacitinibShawn G Kwatra, Marjolein De Bruin-Weller, Jonathan I Silverberg, et al.
Pageof 10